3.0700
-0.1600
(-4.95%)
At close: April 16 at 4:00:01 PM EDT
3.0702
+0.00
+(0.01%)
Pre-Market: 9:01:47 AM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BELLEMIN JEAN-MARC Chief Financial Officer | Conversion of Exercise of derivative security | Mar 3, 2025 | 56,204 |
| BILINSKY IGOR P Chief Operating Officer | Conversion of Exercise of derivative security | Mar 3, 2025 | 87,578 |
| DUKES IAIN D Director | Purchase | Feb 20, 2024 | 54,000 |
| GRAF FINCKENSTEIN FRIEDRICH Officer | Conversion of Exercise of derivative security | Mar 3, 2025 | 92,913 |
| MAYNARD RYAN D Director | Sale | Nov 12, 2024 | 7,500 |
| MCPEAK MERRILL A Director | Purchase | Feb 20, 2024 | 568,783 |
| PURI RAJ K M.D., PH.D. Officer | Conversion of Exercise of derivative security | Mar 14, 2025 | 201,252 |
| ROTHBAUM WAYNE P Director | Purchase | Feb 20, 2024 | -- |
| VOGT FREDERICK G Chief Executive Officer | Conversion of Exercise of derivative security | Mar 3, 2025 | 349,646 |
| WEISER MICHAEL Director | Purchase | May 31, 2022 | 141,116 |
Related Tickers
IBRX ImmunityBio, Inc.
2.4800
-10.79%
TGTX TG Therapeutics, Inc.
38.21
-2.10%
VKTX Viking Therapeutics, Inc.
23.60
+2.12%
NTLA Intellia Therapeutics, Inc.
6.86
-6.79%
SRPT Sarepta Therapeutics, Inc.
53.94
-0.88%
AXSM Axsome Therapeutics, Inc.
104.47
+0.62%
SMMT Summit Therapeutics Inc.
23.05
-6.38%
DAWN Day One Biopharmaceuticals, Inc.
6.76
-5.98%
FATE Fate Therapeutics, Inc.
1.0500
-6.25%
MDGL Madrigal Pharmaceuticals, Inc.
307.78
-4.15%